Log in to save to my catalogue

Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide

Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7895793

Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide

About this item

Full title

Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide

Author / Creator

Publisher

New York: Springer US

Journal title

Heart failure reviews, 2021-03, Vol.26 (2), p.237-253

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Barth syndrome (BTHS) is a rare, X-linked recessive, infantile-onset debilitating disorder characterized by early-onset cardiomyopathy, skeletal muscle myopathy, growth delay, and neutropenia, with a worldwide incidence of 1/300,000–400,000 live births. The high mortality rate throughout infancy in BTHS patients is related primarily to progressive...

Alternative Titles

Full title

Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7895793

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7895793

Other Identifiers

ISSN

1382-4147

E-ISSN

1573-7322

DOI

10.1007/s10741-020-10031-3

How to access this item